ReproTech Logo

UPMC MAGEE REPRODUCTIVE TISSUE TRANSPLANTATION PROGRAMS

The Fertility Preservation Program and the Center for Reproduction and Transplantation at Magee-Womens Hospital, University of Pittsburgh Medical Center, are currently recruiting patients for research studies on reproductive tissue transplantation. These studies are open to patients who previously cryopreserved and stored ovarian tissue or testicular tissue for future use.

photo of Magee Womens Hospital

For additional information or to enroll in the study, please read more about each program below.

Ovarian Tissue Transplantation

The Fertility Preservation Program and the Center for Reproduction and Transplantation at Magee-Womens Hospital, University of Pittsburgh Medical Center, are recruiting for a research study on ovarian tissue transplantation. This IRB-approved experimental protocol is open to women, between the ages of 18-45 years, who have previously cryopreserved and stored ovarian cortical tissue that is available for autologous transplantation (transplantation back into their own body), have ovarian insufficiency, are candidates for pregnancy (if that is the desired outcome), and have written clearance for the procedure from the physician treating the primary condition (e.g., cancer, bone marrow transplantation, etc.) that created the need for ovarian tissue cryopreservation.

Transplants will be performed by Dr. Ted Lee, the Director of Minimally Invasive Gynecologic Surgery at Magee-Womens Hospital. The program will cover the costs of surgery and transplantation.

For additional information or to enroll in the study, please contact Magee’s program coordinators by phone (412-641-7475) or email fertilitypreservation@upmc.edu.

Testicular Tissue Transplantation

The Fertility Preservation Program and the Center for Reproduction and Transplantation at Magee-Womens Hospital, University of Pittsburgh Medical Center are recruiting for a research study on spermatogonial stem cell transplantation and testicular tissue grafting. This IRB-approved experimental protocol is open to males who are at least Tanner Stage 3 of puberty, have previously cryopreserved and stored testicular tissue that is available for autologous transplantation (transplantation back into their own body), are in reasonably good health, and have written clearance for the procedure from the physician treating the primary condition (e.g., cancer, bone marrow transplantation, etc.) that created the need for testicular tissue cryopreservation.

Transplants will be performed by Dr. Kathleen Hwang, a reproductive urologist in the Center for Reproduction and Transplantation at Magee-Womens Hospital, University of Pittsburgh Medical Center. The program will cover the costs of surgery and transplantation.

For additional information or to enroll in the study, please contact Magee’s program coordinators by phone (412-641-7475) or email fertilitypreservation@upmc.edu.